RxDoctor Payments Data

Gloria Chung

Optometrist · Whitestone, NYNPI 1184853772

Payments from drug & device makers

$4,105in general payments, 2019–2025

Across 214 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$965
  • AbbVie$873
  • Oyster Point Pharma, Inc.$567
  • Novartis$493
  • Mallinckrodt Hospital Products Inc.$367
  • Bausch & Lomb Americas Inc.$180
  • plus $659 from 11 others

What the payments were for

  • Food & beverage$4,00798%
  • Education$982%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,105 in reported general payments places this provider in the 90th percentile of 2,743 optometrist providers in New York.

See all optometrist providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine356$371,836
XiidraLifitegrast77$93,384
LumiganBimatoprost139$73,182
CequaCyclosporine31$28,058
CombiganBrimonidine Tartrate/Timolol24$11,979
Alphagan PBrimonidine Tartrate23$11,267
RhopressaNetarsudil Mesylate22$10,621
Cyclosporine19$8,760
Brimonidine Tartrate46$8,390
Latanoprost263$2,884
Timolol Maleate79$1,805
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat42$517
Dorzolamide Hcl12$363
Azelastine Hcl13$283

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan, Combigan, Alphagan P$873$468,264542 claims
Bausch & Lomb Americas Inc.Xiidra$180$93,38477 claims
Sun Pharmaceutical Industries Inc.Cequa$965$28,05831 claims
Aerie Pharmaceuticals, Inc.Rhopressa$70$10,62122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,743 optometrist providers in New York.

Other optometrist in Whitestone

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →